Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,973
Total Claims
$1.1M
Drug Cost
243
Beneficiaries
$4,685
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+339%
Cost per patient vs peers
$4,685 vs $1,068 avg
+124%
Brand preference vs peers
20.1% vs 9.0% avg
Brand vs Generic
Brand: 2,546 claims · $958K
Generic: 10,096 claims · $174K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 286 | $276K |
| Empagliflozin | 260 | $159K |
| Etanercept | 13 | $89K |
| Apixaban | 123 | $72K |
| Tiotropium Bromide | 71 | $38K |
| Rivaroxaban | 62 | $34K |
| Rosuvastatin Calcium | 1,039 | $33K |
| Insulin Aspart | 44 | $26K |
| Fluticasone Propion/Salmeterol | 78 | $22K |
| Ipratropium/Albuterol Sulfate | 41 | $21K |
| Saxagliptin Hcl | 45 | $20K |
| Insulin Aspart Prot/Insuln Asp | 18 | $16K |
| Levothyroxine Sodium | 417 | $16K |
| Insulin Detemir | 28 | $15K |
| Ticagrelor | 30 | $13K |
Prescribing Profile
Patient Profile
71
Avg Age
54%
Female
1.29
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data